Fibroblast Therapy

FibroBiologics Secures U.S. Patent for Disc Regeneration

Houston, Texas, September 1, 2026 FibroBiologics, Inc. has announced the issuance of a new U.S. patent covering a potential...

By cGxPwire Editor
September 3, 2026

MedTech

IceCure Advances Breast Cancer Cryoablation Study

Caesarea, Israel, August 20, 2026 IceCure Medical has announced an important clinical development for its minimally invasive ProSense® cryoablation...

By cGxPwire Editor
August 22, 2026

Bio-Pharma

FibroBiologics Gains Australian Patent for Disc Therapy

Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...

By cGxPwire Editor
August 22, 2026

Bio-Pharma

FibroBiologics Advances CYWC628 DFU Trial Manufacturing

HOUSTON, July 7, 2026 FibroBiologics, Inc. has announced the successful completion of the third manufacturing batch of its investigational...

By cGxPwire Editor
July 10, 2026

Bio-Pharma

FibroBiologics Reports Durable Psoriasis Immunomodulation Data at SID 2026

HOUSTON, May 22, 2026 FibroBiologics, Inc. announced new preclinical data from its CYPS317 psoriasis program demonstrating durable immune modulation...